Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Breast Cancer Research

Fig. 3

From: Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)

Fig. 3

Kaplan–Meier curves of overall survival (left column) and disease-free survival (right column) for pre/perimenopausal women (a, b) and postmenopausal women (c, d). P values are given for the univariate analyses of the Cox regression analyses. DFS, disease-free survival; OS, overall survival

Back to article page